104 related articles for article (PubMed ID: 38729340)
1. Inter-individual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors - a genome-wide association study: results from PanCareLIFE.
van der Perk MEM; Broer L; Yasui Y; Laven JSE; Robison LL; Tissing WJE; Versluys B; Bresters D; Kaspers GJL; Lambalk CB; Overbeek A; Loonen JJ; Beerendonk CCM; Byrne J; Berger C; Clemens E; van Dulmen-den Broeder E; Dirksen U; van der Pal HJ; de Vries ACH; Winther JF; Ranft A; Fosså SD; Grabow D; Muraca M; Kaiser M; Kepák T; Kruseova J; Modan-Moses D; Spix C; Zolk O; Kaatsch P; Kremer LCM; Brooke RJ; Wang F; Baedke JL; Uitterlinden AG; Bos AME; van Leeuwen FE; Ness KK; Hudson MM; van der Kooi ALF; van den Heuvel-Eibrink MM;
Fertil Steril; 2024 May; ():. PubMed ID: 38729340
[TBL] [Abstract][Full Text] [Related]
2. Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function.
van der Kooi ALF; van Dijk M; Broer L; van den Berg MH; Laven JSE; van Leeuwen FE; Lambalk CB; Overbeek A; Loonen JJ; van der Pal HJ; Tissing WJ; Versluys B; Bresters D; Beerendonk CCM; Ronckers CR; van der Heiden-van der Loo M; Kaspers GL; de Vries ACH; Robison LL; Hudson MM; Chemaitilly W; Byrne J; Berger C; Clemens E; Dirksen U; Winther JF; Fosså SD; Grabow D; Haupt R; Kaiser M; Kepak T; Kruseova J; Modan-Moses D; Pluijm SMF; Spix C; Zolk O; Kaatsch P; Krijthe JH; Kremer LC; Yasui Y; Brooke RJ; Uitterlinden AG; van den Heuvel-Eibrink MM; van Dulmen-den Broeder E
Hum Reprod; 2021 Mar; 36(4):1120-1133. PubMed ID: 33582778
[TBL] [Abstract][Full Text] [Related]
3. Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study.
van der Perk MEM; Broer L; Yasui Y; Robison LL; Hudson MM; Laven JSE; van der Pal HJ; Tissing WJE; Versluys B; Bresters D; Kaspers GJL; de Vries ACH; Lambalk CB; Overbeek A; Loonen JJ; Beerendonk CCM; Byrne J; Berger C; Clemens E; Dirksen U; Winther JF; Fosså SD; Grabow D; Muraca M; Kaiser M; Kepák T; Kruseova J; Modan-Moses D; Spix C; Zolk O; Kaatsch P; Krijthe JH; Kremer LCM; Brooke RJ; Baedke JL; van Schaik RHN; van den Anker JN; Uitterlinden AG; Bos AME; van Leeuwen FE; van Dulmen-den Broeder E; van der Kooi ALF; van den Heuvel-Eibrink MM; On Behalf Of The PanCareLIFE Consortium
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572825
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation may modify ovarian reserve in female childhood cancer survivors.
van Dorp W; van den Heuvel-Eibrink MM; Stolk L; Pieters R; Uitterlinden AG; Visser JA; Laven JS
Hum Reprod; 2013 Apr; 28(4):1069-76. PubMed ID: 23360674
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
[TBL] [Abstract][Full Text] [Related]
6. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy.
Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR
J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632
[TBL] [Abstract][Full Text] [Related]
7. Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE).
van den Berg MH; van Dijk M; Byrne J; Berger C; Dirksen U; Winther JF; Fossa SD; Grabow D; Grandage VL; Haupt R; van den Heuvel-Eibrink MM; Kaiser M; Kepak T; van der Kooi ALF; Kremer LCM; Kruseova J; Lambalk CB; van Leeuwen FE; Leiper A; Modan-Moses D; Spix C; Twisk JWR; Ronckers CM; Kaatsch P; van Dulmen-den Broeder E;
Hum Reprod; 2021 May; 36(6):1561-1573. PubMed ID: 33744927
[TBL] [Abstract][Full Text] [Related]
8. Leuprolide Protects Ovarian Reserve in Adolescents Undergoing Gonadotoxic Therapy.
Hoyos-Martinez A; Scheurer ME; Allen-Rhoades W; Okcu MF; Horne VE
J Adolesc Young Adult Oncol; 2023 Dec; 12(6):828-834. PubMed ID: 36976803
[No Abstract] [Full Text] [Related]
9. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol.
van der Kooi ALF; Clemens E; Broer L; Zolk O; Byrne J; Campbell H; van den Berg M; Berger C; Calaminus G; Dirksen U; Winther JF; Fosså SD; Grabow D; Haupt R; Kaiser M; Kepak T; Kremer L; Kruseova J; Modan-Moses D; Ranft A; Spix C; Kaatsch P; Laven JSE; van Dulmen-den Broeder E; Uitterlinden AG; van den Heuvel-Eibrink MM;
BMC Cancer; 2018 Sep; 18(1):930. PubMed ID: 30257669
[TBL] [Abstract][Full Text] [Related]
11. Early Detection of Ovarian Dysfunction by Anti-Mullerian Hormone in Adolescent and Young Adult-Aged Survivors of Childhood Cancer.
George SA; Williamson Lewis R; Schirmer DA; Effinger KE; Spencer JB; Mertens AC; Meacham LR
J Adolesc Young Adult Oncol; 2019 Feb; 8(1):18-25. PubMed ID: 30281375
[TBL] [Abstract][Full Text] [Related]
12. The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-Müllerian Hormone.
Drechsel KCE; Broer SL; Stoutjesdijk FS; van Dulmen-den Broeder E; Beishuizen A; Wallace WH; Körholz D; Mauz-Körholz C; Hasenclever D; Cepelova M; Uyttebroeck A; Ronceray L; Twisk JWR; Kaspers GJL; Veening MA
Hum Reprod; 2024 May; ():. PubMed ID: 38794915
[TBL] [Abstract][Full Text] [Related]
13. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.
Lunsford AJ; Whelan K; McCormick K; McLaren JF
Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve.
van den Berg MH; Overbeek A; Lambalk CB; Kaspers GJL; Bresters D; van den Heuvel-Eibrink MM; Kremer LC; Loonen JJ; van der Pal HJ; Ronckers CM; Tissing WJE; Versluys AB; van der Heiden-van der Loo M; Heijboer AC; Hauptmann M; Twisk JWR; Laven JSE; Beerendonk CCM; van Leeuwen FE; van Dulmen-den Broeder E;
Hum Reprod; 2018 Aug; 33(8):1474-1488. PubMed ID: 29982673
[TBL] [Abstract][Full Text] [Related]
15. Anti-Müllerian hormone screening to assess ovarian reserve among female survivors of childhood cancer.
Charpentier AM; Chong AL; Gingras-Hill G; Ahmed S; Cigsar C; Gupta AA; Greenblatt E; Hodgson DC
J Cancer Surviv; 2014 Dec; 8(4):548-54. PubMed ID: 24810980
[TBL] [Abstract][Full Text] [Related]
16. Serum anti-Müllerian hormone as a marker of ovarian reserve after cancer treatment and/or hematopoietic stem cell transplantation in childhood: proposal for a systematic approach to gonadal assessment.
Molinari S; Parissone F; Evasi V; De Lorenzo P; Valsecchi MG; Cesaro S; Fraschini D; Sangalli R; Cacace G; Biondi A; Balduzzi A; Cattoni A
Eur J Endocrinol; 2021 Oct; 185(5):717-728. PubMed ID: 34519276
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide association studies identify novel genetic loci for epigenetic age acceleration among survivors of childhood cancer.
Dong Q; Song N; Qin N; Chen C; Li Z; Sun X; Easton J; Mulder H; Plyler E; Neale G; Walker E; Li Q; Ma X; Chen X; Huang IC; Yasui Y; Ness KK; Zhang J; Hudson MM; Robison LL; Wang Z
Genome Med; 2022 Mar; 14(1):32. PubMed ID: 35313970
[TBL] [Abstract][Full Text] [Related]
18. Modeling Variation in the Reproductive Lifespan of Female Adolescent and Young Adult Cancer Survivors Using AMH.
Su HI; Kwan B; Whitcomb BW; Shliakhsitsava K; Dietz AC; Stark SS; Martinez E; Sluss PM; Sammel MD; Natarajan L
J Clin Endocrinol Metab; 2020 Aug; 105(8):2740-51. PubMed ID: 32270202
[TBL] [Abstract][Full Text] [Related]
19. Reproductive ability in survivors of childhood, adolescent, and young adult Hodgkin lymphoma: a review.
Drechsel KCE; Pilon MCF; Stoutjesdijk F; Meivis S; Schoonmade LJ; Wallace WHB; van Dulmen-den Broeder E; Beishuizen A; Kaspers GJL; Broer SL; Veening MA
Hum Reprod Update; 2023 Jul; 29(4):486-517. PubMed ID: 36779325
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal follow-up in female Childhood Cancer Survivors: no signs of accelerated ovarian function loss.
van der Kooi AL; van den Heuvel-Eibrink MM; van Noortwijk A; Neggers SJ; Pluijm SM; van Dulmen-den Broeder E; van Dorp W; Laven JS
Hum Reprod; 2017 Jan; 32(1):193-200. PubMed ID: 27821706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
